Effects of daily administration of the glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, N-Acetyl-GIP, in streptozotocin-incluced diabetic mice

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)40-41
JournalDiabetic medicine
Volume24
Issue numberSuppl.
Publication statusPublished (in print/issue) - Mar 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this